Combination therapy for Alzheimer's disease and related dementias

Area of Science:

• Neuroscience
• Neurology
• Pharmacology

Background:

• Numerous disease-modifying therapies for Alzheimer's disease and related dementias have failed.
• Sporadic neurodegenerative dementias often result from multiple toxic protein species.
• Existing therapeutic strategies have not adequately addressed the complexity of these conditions.

Purpose of the Study:

• To advocate for a paradigm shift in therapeutic interventions for Alzheimer's disease and related dementias.
• To emphasize the need to acknowledge and target multiple toxic mechanisms in neurodegenerative diseases.
• To highlight the potential of a pleiotropic and personalized approach to treatment.

Main Methods:

• This study is a conceptual review and does not involve experimental methods.
• It analyzes the limitations of current therapeutic strategies for neurodegenerative dementias.
• It proposes a new framework for future clinical trial designs.

Main Results:

• The failure of single-target therapies underscores the multifactorial nature of neurodegenerative dementias.
• Clinical trials targeting multiple mechanisms present challenges but are necessary.
• A personalized, pleiotropic approach offers a promising direction for effective treatment.

Conclusions:

• A fundamental rethinking of therapeutic strategies for Alzheimer's disease and related dementias is urgently required.
• Future interventions must address the polygenic and multifactorial etiology of these conditions.
• Implementing a pleiotropic and personalized treatment paradigm is essential to mitigate the impact of neurodegenerative dementias.